J&J | JNJ - Stock

Aktienkurs
227.51
Täglich Wechseln
-3.14 -1.36%
Monatlich
-3.30%
Jährlich
46.85%
Q2 Prognose
229.03




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Abbott USD 6.49B 220M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Baxter International USD 2.23B 228M 2025-12
Bayer EUR 12.33B 221M 2025-09
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Biogen USD 2.17B 41.3M 2025-12
Boston Scientific USD 2.94B 22M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
CONMED USD 355.54M 8.81M 2025-12
Cooper Companies USD 846M 35M 2025-09
Dexcom USD 629.1M 25M 2025-12
Edwards Lifesciences USD 1.13B 14.7M 2025-12
Eli Lilly USD 13.74B 1.56B 2025-12
Gilead Sciences USD 1.77B 11M 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
Globus Medical USD 759.28M 12.26M 2025-12
Insulet USD 452.6M 6.3M 2025-12
Integra LifeSciences USD 492.73M 3.63M 2025-12
Intuitive Surgical USD 1.95B 105.1M 2026-03
J&J USD 14.58B 392M 2026-03
Medtronic USD 6.31B 153M 2025-12
Merck USD 6.44B 157M 2025-09
Merit Medical Systems USD 333.7M 7.15M 2025-12
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
Stryker USD 5.31B 60M 2025-12
Tandem Diabetes Care USD 128.77M 8.51M 2025-12
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12
Zimmer Biomet Holdings USD 2.29B 197.3M 2025-12
Zoetis USD 2.43B 35M 2025-12